Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer

Authors:

Abstract
[18F]Fluciclovine (anti-[18F]FACBC) is a synthetic amino acid developed for PET assessment of the anabolic component of tumour metabolism in clinical routine. This phase 1 trial evaluated the safety, tracer stability and uptake kinetics of [18F]fluciclovine in patients.

This publication has 26 references indexed in Scilit: